Drug Importation

Blog

The 340B Discounts Hospitals Receive Will Often Exceed Total Drug Prices in Europe

Table 1: PBM Fees and Rebates Can Exceed International Prescription Medicine Prices by As Much As 900% I previously highlighted how estimated rebates and fees PBMs receive for 10 commonly used brand medicines far exceed the total prices of those medicines in eight OECD countries (see Table 1). For example, ...
Drug Importation

Listen to Sally Pipes on “Free the Economy” podcast

Listen to PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes discuss her new book The World’s Medicine Chest (Encounter Books) on the Free the Economy podcast from the Competitive Enterprise Institute. Click here to listen
Commentary

Tying U.S. Drug Prices To Foreign Markets Risks Innovation And Lives

Earlier this month, President Donald Trump signed what he called “one of the most consequential Executive Orders in our Country’s history.” The order is essentially an updated version of his administration’s 2020 “Most Favored Nation” policy. It directs pharmaceutical companies to tie the U.S. prices of their drugs to the ...
Commentary

Trump’s ‘Most Favored Nation’ Drug Plan Doesn’t Favor Americans

Last week, President Donald Trump revived one of the most ill-conceived health policy ideas of his first term. Via a new executive order, he’s directed his administration to deliver “most-favored-nation prescription drug pricing to American patients.” The idea is to bring other developed countries’ lower drug prices to the United ...
Drug Importation

Pipes: “Imposing tariffs on pharmaceutical products and ingredients would be a grave mistake”

Click here to download a copy of Pipes’ comments Thank you for inviting public input on the Department’s Section 232 examination of pharmaceutical imports and their relevance to U.S. national security interests. As president and CEO of the Pacific Research Institute and a longtime healthcare policy analyst, I’ve spent over ...
Blog

Imposing Price Controls on U.S. Drugs Won’t Level the Playing Field

The cost of capital for developing a new drug is $2.9 billion, including post approval research and development costs. Meanwhile, the process to develop a drug takes 10 years and only 12 percent of drugs make it to market. These costs do not change simply because governments impose price controls ...
Drug Importation

Sally Pipes – The World’s Medicine Chest

This week, we present a special presentation of our recent webinar with Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy, discussing her new book, The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy – and How to Keep It (Encounter Books). The book explores ...
340B

Watch Webinar with Sally Pipes on her new book, “The World’s Medicine Chest”

Watch the webinar with Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy, discussing her new book, The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy – and How to Keep It (Encounter Books). The book explores how America became the world’s leader in biopharmaceutical ...
Commentary

A Year Later, Florida’s Drug Importation Plan Is Misguided As Ever

When president-elect Donald Trump joked about making Canada the 51st state, he had an unlikely supporter: Bernie Sanders. “Does that mean that we can adopt the Canadian health care system and . . . lower the cost of prescription drugs,” the Vermont senator wrote on X. “I’m all for it.” ...
Commentary

Drug price controls hurt patients

Costly Imported Medicines Leave Patients Vulnerable

Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Blog

The 340B Discounts Hospitals Receive Will Often Exceed Total Drug Prices in Europe

Table 1: PBM Fees and Rebates Can Exceed International Prescription Medicine Prices by As Much As 900% I previously highlighted how estimated rebates and fees PBMs receive for 10 commonly used brand medicines far exceed the total prices of those medicines in eight OECD countries (see Table 1). For example, ...
Drug Importation

Listen to Sally Pipes on “Free the Economy” podcast

Listen to PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes discuss her new book The World’s Medicine Chest (Encounter Books) on the Free the Economy podcast from the Competitive Enterprise Institute. Click here to listen
Commentary

Tying U.S. Drug Prices To Foreign Markets Risks Innovation And Lives

Earlier this month, President Donald Trump signed what he called “one of the most consequential Executive Orders in our Country’s history.” The order is essentially an updated version of his administration’s 2020 “Most Favored Nation” policy. It directs pharmaceutical companies to tie the U.S. prices of their drugs to the ...
Commentary

Trump’s ‘Most Favored Nation’ Drug Plan Doesn’t Favor Americans

Last week, President Donald Trump revived one of the most ill-conceived health policy ideas of his first term. Via a new executive order, he’s directed his administration to deliver “most-favored-nation prescription drug pricing to American patients.” The idea is to bring other developed countries’ lower drug prices to the United ...
Drug Importation

Pipes: “Imposing tariffs on pharmaceutical products and ingredients would be a grave mistake”

Click here to download a copy of Pipes’ comments Thank you for inviting public input on the Department’s Section 232 examination of pharmaceutical imports and their relevance to U.S. national security interests. As president and CEO of the Pacific Research Institute and a longtime healthcare policy analyst, I’ve spent over ...
Blog

Imposing Price Controls on U.S. Drugs Won’t Level the Playing Field

The cost of capital for developing a new drug is $2.9 billion, including post approval research and development costs. Meanwhile, the process to develop a drug takes 10 years and only 12 percent of drugs make it to market. These costs do not change simply because governments impose price controls ...
Drug Importation

Sally Pipes – The World’s Medicine Chest

This week, we present a special presentation of our recent webinar with Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy, discussing her new book, The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy – and How to Keep It (Encounter Books). The book explores ...
340B

Watch Webinar with Sally Pipes on her new book, “The World’s Medicine Chest”

Watch the webinar with Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy, discussing her new book, The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy – and How to Keep It (Encounter Books). The book explores how America became the world’s leader in biopharmaceutical ...
Commentary

A Year Later, Florida’s Drug Importation Plan Is Misguided As Ever

When president-elect Donald Trump joked about making Canada the 51st state, he had an unlikely supporter: Bernie Sanders. “Does that mean that we can adopt the Canadian health care system and . . . lower the cost of prescription drugs,” the Vermont senator wrote on X. “I’m all for it.” ...
Commentary

Drug price controls hurt patients

Costly Imported Medicines Leave Patients Vulnerable

Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Scroll to Top